Tranylcypromine
Top View
- Inhibition of Monoamine Oxidase by Derivatives of Piperine, an Alkaloid
- Drug-Induced Parkinsonism
- BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
- Contribution of Harman and Norharman to the Reinforcing Efficacy of Aqueous Tobacco Smoke Extract Self-Administered by Rats by A
- The Inhibition of Noradrenaline Uptake by Sympathomimetic Amines in the Rat Isolated Heart
- Antidepressants: Mechanism of Action, Toxicity and Possible Amelioration
- Differential Effects of the MAO Inhibitors Deprenyl, Moclobemide and Pargyline on Effort- Related Choice Behavior Hector M
- Maois in the Contemporary Treatment of Depression Michael E
- Insights Into the Mode of Inhibition of Human Mitochondrial Monoamine Oxidase B from High-Resolution Crystal Structures
- Meta-Analysis of the Reversible Inhibitors of Monoamine Oxidase
- Opioids and Antidepressants: Which Combinations to Avoid
- Amphetamines: Structure- Activity Relationships
- Modafinil Enhances Two-Year Outcome from Monoamine Oxidase Inhibitor Therapy in 3 Patients with Treatment-Resistant Depression
- Effects of Opioids on Neuronal Nicotinic Acetylcholine Receptors Recent Publications in This Series
- Commonly Prescribed Psychotropic Medications
- 510(K) SUBSTANTIAL EQUIVALENCE DETERMINATION CHECKLIST
- Medication Guide
- Prescribing Framework for Tranylcypromine in the Treatment of Depressive Illness